FDA clears Propeller Health sensor for use with AstraZeneca ' s Symbicort inhaler
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Asthma | AstraZeneca | Chronic Obstructive Pulmonary | Information Technology | Respiratory Medicine | Symbicort